Researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology—an emerging technology that uses ...
In 2025, biopharma companies increasingly invested in Europe-based contract manufacturing for FDA-approved drugs compared to ...
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy ...
In the early 2020s, interest in GLP-1 weight loss drugs exploded. Now, as we move deeper into the decade, a new buzzword is taking over: peptides.
That company is Digital Vision Pharma, owned by Ambala-based businessman Parshotam Lal Goyal, with his sons Konic and Manic Goyal as directors. It publicly touts an “unflinching dedication to ...
The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...
Opinion
6dOpinion
New I-MAK report documents how drug manufacturers extend monopoly pricing — costing Medicare and patients billions
Case studies of blockbuster drugs reveal a repeatable playbook of patent strategies that delay competition well beyond ...
Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy ...
Companies that make compounded drugs obtain semaglutide API from authorized and registered chemical manufacturers.
Experts say those shortages are often tied to the United States’ heavy reliance on overseas drug manufacturing — a supply chain that can quickly unravel when a major plant is ...
Deputies say investigators recovered drugs, stolen firearms and manufacturing equipment during an operation in Sylvania.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results